[ad_1]
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the Brazilian variant (P1), a source familiar with the study told Reuters.
The data indicates that the vaccine will not have to be modified to protect against the variant believed to have originated in the Amazon city of Manaus, said the source, who asked to remain anonymous because the results have not yet been made public, writes mediafax. . ro.
Also read: Denise Rifai draws the attention of Klaus Iohannis and the Government of Cîțu: ‘The precedent that would be created is much more dangerous even than the beating received by the Romanians on August 10’
The source did not specify the exact effectiveness of the P1 vaccine and said the full results of the study should be published soon, possibly in March.
Early results indicated that the AstraZeneca vaccine was less effective against the South African variant, which is similar to P1. Subsequently, South Africa suspended use of the vaccine in the country.
Also read: Nicușor Dan reveals the status of the relationship with NLP and USR PLUS: ‘As long as they ask me for individual meetings, I speak, because we have regular meetings every two weeks with all mayors’
Brazil is currently facing a brutal and long-lasting second wave of the coronavirus, reaching a record 1,910 deaths on Wednesday.
The P1 variant is one of the factors that epidemiologists believe contributes to an increase in cases and deaths, and the scientific community has raised concerns about the variant’s resistance to vaccines.
Also read: Elena Udrea: ‘I am a free man, I have a son, I want to raise him in freedom. Why should people who don’t believe in God be afraid of curses? ‘.
[ad_2]
